Opus Genetics, Inc. SEC filings IRD

Opus Genetics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 17, 2005. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.

Opus Genetics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 21, 2026 Oct 19, 2026
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 14, 2026
8-K Current report
Regulation FD disclosure
Sep 11, 2026 Sep 11, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 9, 2026 Sep 9, 2026
EFFECT Filing Aug 14, 2026 —
CORRESP Letter to the SEC Aug 13, 2026 —
UPLOAD Letter from the SEC Aug 12, 2026 —
S-3 Shelf registration Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
424B2 Prospectus Jun 17, 2026 —
8-K Current report
Regulation FD disclosure
Jun 16, 2026 Jun 16, 2026
8-K Current report
Regulation FD disclosure
Jun 16, 2026 Jun 16, 2026
EFFECT Filing Jun 15, 2026 —
CORRESP Letter to the SEC Jun 11, 2026 —
UPLOAD Letter from the SEC Jun 10, 2026 —
S-3 Shelf registration Jun 5, 2026 —
S-8 Employee stock plan registration May 14, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
New debt
Apr 24, 2026 Apr 21, 2026
EFFECT Filing Apr 22, 2026 —
8-K Current report
Shareholder vote results
Apr 22, 2026 Apr 20, 2026
CORRESP Letter to the SEC Apr 21, 2026 —
S-3/A Filing Apr 21, 2026 —
8-K Current report
Officer or director change
Apr 7, 2026 Apr 1, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 7, 2026 Apr 2, 2026
ARS Annual report to shareholders Mar 23, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 23, 2026 Apr 20, 2026
UPLOAD Letter from the SEC Mar 17, 2026 —
S-3 Shelf registration Mar 13, 2026 —
PRE 14A Preliminary proxy statement Mar 12, 2026 Apr 20, 2026
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Bylaw or fiscal year change, Other events
Feb 19, 2026 Feb 13, 2026
S-8 Employee stock plan registration Jan 22, 2026 —
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
8-K Current report
Other events
Dec 19, 2025 Dec 17, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Material agreement, Other events
Nov 6, 2025 Nov 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 6, 2025 Nov 6, 2025
FWP Free writing prospectus Nov 6, 2025 —
424B5 Prospectus supplement Nov 6, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2025 Sep 30, 2025
S-8 Employee stock plan registration Sep 26, 2025 —
S-8 Employee stock plan registration Sep 10, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2025 Aug 29, 2025
8-K Current report
Unregistered share sale
Aug 25, 2025 Aug 25, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jul 23, 2025 Jul 22, 2025
424B5 Prospectus supplement Jun 26, 2025 —
8-K Current report
Other events
Jun 26, 2025 Jun 26, 2025
8-K Current report
Officer or director change
Jun 25, 2025 Jun 25, 2025
8-K Current report
Regulation FD disclosure
Jun 23, 2025 Jun 23, 2025
8-K Current report
Material agreement
Jun 20, 2025 Jun 13, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Shareholder vote results
May 1, 2025 Apr 30, 2025
DEFA14A Additional proxy material Apr 14, 2025 —
PX14A6G Filing Apr 11, 2025 —
DEFA14A Additional proxy material Apr 11, 2025 —
EFFECT Filing Apr 10, 2025 —
DEFA14A Additional proxy material Apr 10, 2025 —
DFAN14A Filing Apr 9, 2025 —
CORRESP Letter to the SEC Apr 9, 2025 —
CORRESP Letter to the SEC Apr 8, 2025 —
S-3/A Filing Apr 8, 2025 —
CORRESP Letter to the SEC Apr 7, 2025 —
DEFA14A Additional proxy material Apr 7, 2025 —
8-K Current report
Agreement ended
Apr 4, 2025 Apr 2, 2025
424B5 Prospectus supplement Apr 4, 2025 —
PRRN14A Filing Apr 4, 2025 —
DEFC14A Preliminary proxy statement Apr 2, 2025 —
DFAN14A Filing Apr 2, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
PRER14A Preliminary proxy statement Mar 31, 2025 —
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
UPLOAD Letter from the SEC Mar 28, 2025 —
DFAN14A Filing Mar 28, 2025 —
8-K Current report
Unregistered share sale, Other events
Mar 24, 2025 Mar 21, 2025
424B5 Prospectus supplement Mar 24, 2025 —
DFAN14A Filing Mar 21, 2025 —
PRER14A Preliminary proxy statement Mar 21, 2025 —
PREC14A Filing Mar 21, 2025 —
FWP Free writing prospectus Mar 21, 2025 —
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
FWP Free writing prospectus Mar 20, 2025 —
424B5 Prospectus supplement Mar 20, 2025 —
PREC14A Preliminary proxy statement Mar 20, 2025 —
8-K Current report
Bylaw or fiscal year change, Other events
Mar 20, 2025 Mar 19, 2025
8-K Current report
Other events
Mar 4, 2025 Mar 4, 2025
UPLOAD Letter from the SEC Feb 26, 2025 —
S-3 Shelf registration Feb 18, 2025 —
DFAN14A Filing Feb 7, 2025 —
8-K Current report
Officer or director change
Jan 24, 2025 Jan 17, 2025
8-K Current report
Other events
Jan 23, 2025 Jan 23, 2025
8-K Current report
Other events
Jan 14, 2025 Jan 13, 2025
424B5 Prospectus supplement Jan 13, 2025 —
8-K/A Amended current report Jan 7, 2025 Oct 22, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
D Filing Nov 7, 2024 —
S-8 Employee stock plan registration Nov 4, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Results of operations, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Oct 22, 2024 Oct 22, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 13, 2024 Jun 11, 2024
DEFR14A Filing May 30, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure
May 10, 2024 May 10, 2024
8-K Current report
Results of operations
May 10, 2024 May 10, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 11, 2024
8-K Current report
Officer or director change
Apr 17, 2024 Apr 11, 2024
8-K Current report
Regulation FD disclosure
Mar 27, 2024 Mar 27, 2024
10-K Annual report Mar 8, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 8, 2024 Mar 8, 2024
424B3 Prospectus Feb 16, 2024 —
8-K Current report
Officer or director change
Feb 16, 2024 Feb 12, 2024
EFFECT Filing Jan 23, 2024 —
CORRESP Letter to the SEC Jan 22, 2024 —
UPLOAD Letter from the SEC Jan 19, 2024 —
S-8 Employee stock plan registration Jan 11, 2024 —
S-3 Shelf registration Jan 10, 2024 —
8-K Current report
Officer or director change
Dec 6, 2023 Dec 1, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 27, 2023 Nov 20, 2023
S-8 Employee stock plan registration Nov 21, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 2, 2023 Nov 2, 2023
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Nov 1, 2023 Oct 30, 2023
8-K Current report
Other events
Sep 27, 2023 Sep 25, 2023
424B5 Prospectus supplement Aug 14, 2023 —
8-K Current report
Material agreement, Results of operations
Aug 11, 2023 Aug 10, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure
Aug 1, 2023 Aug 1, 2023
UPLOAD Letter from the SEC Jul 12, 2023 —
CORRESP Letter to the SEC Jul 7, 2023 —
UPLOAD Letter from the SEC Jun 28, 2023 —
8-K Current report
Officer or director change
Jun 14, 2023 Jun 8, 2023
8-K Current report
Shareholder vote results
Jun 9, 2023 Jun 6, 2023
8-K Current report
Bylaw or fiscal year change
Jun 2, 2023 Jun 1, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2023 May 15, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEF 14A Proxy statement May 1, 2023 Jun 6, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 21, 2023 Apr 19, 2023
S-8 Employee stock plan registration Apr 5, 2023 —
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 25, 2023 Jan 25, 2023
8-K Current report
Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Material agreement
Nov 7, 2022 Nov 6, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 4, 2022 Nov 4, 2022
8-K Current report
Regulation FD disclosure
Oct 14, 2022 Oct 14, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2022 Aug 12, 2022
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 17, 2022 Jun 13, 2022
DEFA14A Additional proxy material Jun 10, 2022 —
8-K Current report
Bylaw or fiscal year change
Jun 10, 2022 Jun 10, 2022
DEFA14A Additional proxy material Jun 2, 2022 —
8-K Current report
Regulation FD disclosure, Other events
May 19, 2022 May 19, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
8-K Current report
Other events
Apr 28, 2022 Apr 28, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 13, 2022
S-8 Employee stock plan registration Apr 5, 2022 —
8-K Current report
Regulation FD disclosure, Other events
Mar 29, 2022 Mar 29, 2022
10-K Annual report Mar 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 24, 2022 Mar 24, 2022
8-K Current report
Regulation FD disclosure
Jan 31, 2022 Jan 31, 2022
8-K Current report
Other events
Jan 31, 2022 Jan 31, 2022
8-K Current report
Regulation FD disclosure
Jan 5, 2022 Jan 5, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 15, 2021 Nov 12, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2021 Aug 12, 2021
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2021 Jun 30, 2021
8-K Current report
Material agreement
Jun 23, 2021 Jun 16, 2021
8-K Current report
Shareholder vote results, Other events
Jun 8, 2021 Jun 7, 2021
424B5 Prospectus supplement Jun 7, 2021 —
8-K/A Amended current report
Material agreement, Other events
Jun 7, 2021 Jun 4, 2021
8-K Current report
Material agreement, Other events
Jun 4, 2021 Jun 4, 2021
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 7, 2021 May 7, 2021
DEFA14A Additional proxy material Apr 26, 2021 —
DEF 14A Proxy statement Apr 26, 2021 Jun 7, 2021
8-K Current report
Other events
Apr 12, 2021 Apr 9, 2021
S-8 Employee stock plan registration Mar 31, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Mar 15, 2021 Mar 15, 2021
424B5 Prospectus supplement Mar 11, 2021 —
8-K Current report
Results of operations
Mar 11, 2021 Mar 10, 2021
8-K Current report
Material agreement
Mar 11, 2021 Mar 11, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1228627
Former names
Ocuphire Pharma, Inc. (until Oct 22, 2024); REXAHN PHARMACEUTICALS, INC. (until Nov 9, 2020); CORPORATE ROAD SHOW DOT COM INC (until Apr 29, 2005); FERRARO FRANK (until Apr 29, 2003)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.